Proteomic patterns of tumour subsets in non-small-cell lung cancer
- PMID: 12927430
- DOI: 10.1016/S0140-6736(03)14068-8
Proteomic patterns of tumour subsets in non-small-cell lung cancer
Abstract
Background: Proteomics-based approaches complement the genome initiatives and may be the next step in attempts to understand the biology of cancer. We used matrix-assisted laser desorption/ionisation mass spectrometry directly from 1-mm regions of single frozen tissue sections for profiling of protein expression from surgically resected tissues to classify lung tumours.
Methods: Proteomic spectra were obtained and aligned from 79 lung tumours and 14 normal lung tissues. We built a class-prediction model with the proteomic patterns in a training cohort of 42 lung tumours and eight normal lung samples, and assessed their statistical significance. We then applied this model to a blinded test cohort, including 37 lung tumours and six normal lung samples, to estimate the misclassification rate.
Findings: We obtained more than 1600 protein peaks from histologically selected 1 mm diameter regions of single frozen sections from each tissue. Class-prediction models based on differentially expressed peaks enabled us to perfectly classify lung cancer histologies, distinguish primary tumours from metastases to the lung from other sites, and classify nodal involvement with 85% accuracy in the training cohort. This model nearly perfectly classified samples in the independent blinded test cohort. We also obtained a proteomic pattern comprised of 15 distinct mass spectrometry peaks that distinguished between patients with resected non-small-cell lung cancer who had poor prognosis (median survival 6 months, n=25) and those who had good prognosis (median survival 33 months, n=41, p<0.0001).
Interpretation: Proteomic patterns obtained directly from small amounts of fresh frozen lung-tumour tissue could be used to accurately classify and predict histological groups as well as nodal involvement and survival in resected non-small-cell lung cancer.
Comment in
-
Clinical proteomics--insights into pathologies and benefits for patients.Lancet. 2003 Aug 9;362(9382):415-6. doi: 10.1016/S0140-6736(03)14096-2. Lancet. 2003. PMID: 12927423 No abstract available.
Similar articles
-
Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.J Thorac Oncol. 2008 Aug;3(8):840-50. doi: 10.1097/JTO.0b013e31817e464a. J Thorac Oncol. 2008. PMID: 18670301
-
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.J Natl Cancer Inst. 2007 Jun 6;99(11):858-67. doi: 10.1093/jnci/djk197. J Natl Cancer Inst. 2007. PMID: 17551146 Clinical Trial.
-
Proteomic patterns of preinvasive bronchial lesions.Am J Respir Crit Care Med. 2005 Dec 15;172(12):1556-62. doi: 10.1164/rccm.200502-274OC. Epub 2005 Sep 22. Am J Respir Crit Care Med. 2005. PMID: 16179643 Free PMC article.
-
Proteomic profiling of cancer biomarkers.Brief Funct Genomic Proteomic. 2003 Jul;2(2):147-58. doi: 10.1093/bfgp/2.2.147. Brief Funct Genomic Proteomic. 2003. PMID: 15239937 Review.
-
Proteomic analysis of gliomas.Br J Neurosurg. 2007 Dec;21(6):576-82. doi: 10.1080/02688690701721691. Br J Neurosurg. 2007. PMID: 18071984 Review.
Cited by
-
Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL.J Clin Immunol. 2012 Oct;32(5):1129-40. doi: 10.1007/s10875-012-9700-5. Epub 2012 May 3. J Clin Immunol. 2012. PMID: 22552860 Free PMC article.
-
Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections.Am J Pathol. 2004 Oct;165(4):1057-68. doi: 10.1016/S0002-9440(10)63367-6. Am J Pathol. 2004. PMID: 15466373 Free PMC article. Review.
-
Discovery of rafoxanide as a novel agent for the treatment of non-small cell lung cancer.Sci Rep. 2023 Jan 13;13(1):693. doi: 10.1038/s41598-023-27403-y. Sci Rep. 2023. PMID: 36639421 Free PMC article.
-
MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer.Am J Pathol. 2011 Dec;179(6):2720-9. doi: 10.1016/j.ajpath.2011.08.032. Epub 2011 Oct 18. Am J Pathol. 2011. PMID: 22015459 Free PMC article.
-
Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma.Turk Gogus Kalp Damar Cerrahisi Derg. 2020 Jan 23;28(1):188-196. doi: 10.5606/tgkdc.dergisi.2020.17279. eCollection 2020 Jan. Turk Gogus Kalp Damar Cerrahisi Derg. 2020. PMID: 32175161 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical